Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Risk of tumorigenicity in mesenchymal stromal cell–based therapies—Bridging scientific observations and regulatory viewpoints
2013
406 citations
Review
Field-Weighted Citation Impact:
11.97
Willem E. Fibbe
·
Leiden University Medical Center
Arnaud Foussat
·
Txcell (France)
Marcel Kwa
·
European Medicines Agency
Olivier Lantz
·
Institut Curie
Romaldas Mačiulaitis
·
Lithuanian University of Health Sciences
Tiina Palomäki
·
Finnish Medicines Agency Fimea
Christian K. Schneider
·
National Board of Health
Luc Sensebé
·
Inserm
Gérard Tachdjian
·
Université Paris-Sud
Karin Tarte
·
Inserm
Lucie Tosca
·
Inserm
Paula Salmikangas
·
Finnish Medicines Agency Fimea
Risk of tumorigenicity in mesenchymal stromal cell–based therapies—Bridging scientific observations and regulatory viewpoints | Researchclopedia